Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of Polypharmacy and Bone Mineral Density: A Cross-Sectional Analysis of Geriatric Inpatients in Germany.

Journal of clinical medicine·2026

Same author

Hydration Status in Geriatric Patients-Subjective Impression or Objective Parameter? The Hydr-Age-Study.

Nutrients·2025

Same author

Validity of the German version of the Stay Independent Questionnaire applied by telephone interview: A diagnostic accuracy study.

PloS one·2025

Same author

Validation of the German falls risk questionnaire, fall risk check (FRC), in community-dwelling seniors : A diagnostic accuracy study.

Zeitschrift fur Gerontologie und Geriatrie·2025

Same author

Prognostic value of cough force measured by peak expiratory flow in a 4-year longitudinal cohort study of geriatric patients with oropharyngeal dysphagia.

Frontiers in aging·2025

Same author

Assessing the effectiveness and cost-effectiveness of a smart home emergency call system: study protocol for a randomised controlled trial in Germany.

BMJ open·2025

Search research articles

Related Experiment Videos

[Patient stratification: interactions between diagnosis and therapy].

Hans Joachim Trampisch¹, Ulrike Sonja Trampisch, Ulrich Thiem

¹Ruhr-Universität Bochum, Abteilung für Medizinische Informatik, Biometrie und Epidemiologie. trampisch@amib.rub

Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen

|October 1, 2011

Summary

Developing accurate diagnostic tests is crucial. These tests must demonstrate predictive value for patient treatment, ideally evaluated within randomized controlled trials to confirm their clinical benefit.

Related Experiment Videos

Area of Science:

Medical diagnostics
Clinical trial design
Therapeutic benefit assessment

Background:

High interest exists in developing novel diagnostic tests, particularly molecular markers.
Diagnostic test evaluation traditionally focuses on accuracy metrics.
The ultimate patient benefit of diagnostic tests is linked to subsequent treatment.

Purpose of the Study:

To highlight the necessity of evaluating the interaction between diagnostic testing and therapy.
To emphasize that diagnostic tests should be predictive of treatment outcomes.
To advocate for embedding diagnostic tests within randomized controlled trials.

Main Methods:

Reviewing the current approach to diagnostic test evaluation.
Conceptualizing the link between diagnostic accuracy and therapeutic benefit.
Proposing randomized controlled trials as the optimal framework for assessment.

Main Results:

Diagnostic test accuracy alone does not guarantee patient benefit.
The benefit of a diagnostic test is realized through its impact on subsequent treatment.
Diagnostic tests that predict therapy are essential for clinical utility.

Conclusions:

Diagnostic tests must be evaluated not only for accuracy but also for their predictive value in guiding therapy.
Randomized controlled trials are essential to demonstrate the clinical utility and patient benefit of diagnostic tests.
Integrating diagnostic and therapeutic strategies is key to improving patient outcomes.